Company news

Becton, Dickinson and Company news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market

January 21, 2026

BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System

January 15, 2026

BD Names Shawn Bevec as Senior Vice President of Investor Relations

January 14, 2026

BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs

January 13, 2026

BD To Host Virtual 2026 Annual Meeting of Shareholders

January 12, 2026

BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial

January 5, 2026

BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry

December 18, 2025

BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec

December 15, 2025

Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity

December 12, 2025

BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories

December 4, 2025

BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes

December 3, 2025

BD Surgiphor™ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety

November 24, 2025

BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors

November 17, 2025

BD Onclarity™ HPV Assay for BD COR™ and BD Viper™ LT Systems Receive WHO Prequalification

November 17, 2025

Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH

November 13, 2025

BD Expands PureWick™ Portfolio with First-of-its-Kind Portable Solution to Confidently Manage Urinary Incontinence On the Go

November 12, 2025

BD Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results

November 6, 2025

BD Board Increases Dividend for 54th Consecutive Year

November 6, 2025

BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease

November 4, 2025

BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-Throughput Enteric Bacterial Panels on BD COR™ System

November 3, 2025

BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States

October 22, 2025

BD Launches New AI-enabled Solutions to Drive Connectivity Across Healthcare Settings

October 20, 2025

BD Looks Ahead to the Next Era of Manufacturing Excellence in Broken Bow, NE and Celebrates 65 Years of Innovation in the Region

October 16, 2025

BD Announces CFO Transition Plan

October 15, 2025

BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2025

October 9, 2025

BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease

October 9, 2025

BD and Opentrons Collaborate to Accelerate Single-Cell Multiomics Discoveries with Robotic Automation

October 8, 2025

BD Celebrates 55 Years of Manufacturing Excellence and Impact in Sumter, S.C.

October 3, 2025

BD and Henry Ford Health Sign Pharmacy Automation Partnership to Revolutionize Medication Storage and Prescription Delivery

September 22, 2025

BD Marks 1,000th BD Rhapsody System, Driving Scientific Breakthroughs via Single-Cell Multiomics

September 17, 2025

Celltrion Pharm Signs Strategic Trilateral Agreement with Becton Dickinson and BD Korea to Accelerate Global PFS CMO Business

September 16, 2025

BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative

September 2, 2025

BD to Present at Wells Fargo 2025 Healthcare Conference

August 14, 2025

BD Reports Third Quarter Fiscal 2025 Financial Results

August 7, 2025

Instylla Appoints MedTech Leader Sean Boyle as Chief Executive Officer

August 5, 2025

BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories

August 5, 2025

BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care

August 4, 2025

BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-Collected At Home

July 31, 2025

BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test

July 30, 2025

BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs

July 23, 2025

BD Board Declares Dividend

July 22, 2025

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

July 14, 2025

BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment

July 7, 2025

BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease

May 28, 2025

BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference

May 27, 2025

BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies

May 13, 2025

BD to Announce Financial Results for its Third Quarter of Fiscal 2025

May 12, 2025

BD Reports Second Quarter Fiscal 2025 Financial Results

May 1, 2025

BD to Present at Bank of America Securities Health Care Conference

April 30, 2025

BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair

April 23, 2025

← Newer news releases · Older news releases →

Calls

The 5 newest of 32 calls. Every call is listed under its year.

Decks

The 5 newest of 67 decks. Every deck is listed under its year.